Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Hidradenitis Suppurativa

Diseases of the Skin and Subcutaneous Tissue

Hidradenitis suppurativa, sometimes known as acne inversa or Verneuil's disease, is a long-term dermatological condition characterized by inflamed and swollen lumps that are typically painful and break open, releasing fluid or pus. The areas most commonly affected are the underarms, under the breasts, the perineum, the buttocks, and the groin, and scar tissue remains after healing. The condition may significantly limit everyday activities such as walking, hugging, moving, and sitting, and prolonged sitting can worsen the skin in affected regions.

Facts
Classification
Body System
Integumentary System 1
ICD-10 Chapter
XII: Diseases of the Skin and Subcutaneous Tissue 1
Communicable or Non-communicable
Non-Communicable 2
Transmission Route
Non-Transmissible 2
Causative Agent
Causative Agent (category)
Idiopathic / Multifactorial 2
First Described
1833 3
Connections

Treated By

Source ChEMBL, EMBL-EBI: Adalimumab approved indications (ChEMBL)
Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter XII
Quote, List of chapters, Chapter XII
Diseases of the skin and subcutaneous tissue
View the Source
2. Hidradenitis Suppurativa (Wikipedia)
Wikipedia
  • Body text, cause statement
    The exact cause is usually unclear but believed to involve a combination of genetic and environmental factors.
  • Infobox: causes
    Unknown
View the Source
3. Hidradenitis Suppurativa (Wikipedia)
Lead section
Quote, Lead section
Hidradenitis suppurativa (HS), sometimes known as acne inversa or Verneuil's disease, is a long-term dermatological condition characterized by the occurrence of inflamed and swollen lumps.
View the Source
Wikidata: Hidradenitis Suppurativa
Wikidata Q341999, class allow-list match (w-wdresolver-0926)View the Source
ChEMBL, EMBL-EBI: Adalimumab approved indications (ChEMBL)
ChEMBL, EMBL-EBITreated By: Adalimumab, drug_indication record, maximum phase 4, MeSH heading Hidradenitis Suppurativa
Quote, Treated By: Adalimumab, drug_indication record, maximum phase 4, MeSH heading Hidradenitis Suppurativa
"max_phase_for_ind": "4.0", "mesh_heading": "Hidradenitis Suppurativa", "molecule_chembl_id": "CHEMBL1201580"
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.